As the MLB season moves deeper into summer, we’re breaking down each division to separate the real threats from the pretenders. For the American League East, the question looms large: Are the Toronto Blue Jays for real, or are they fooling us?
At 18-23, the Blue Jays have stumbled out of the gate. Injuries have ravaged the roster all spring, directly dragging down their record. The biggest surprise isn’t a breakout player—it’s how many key arms have missed time, forcing depth guys into bigger roles.
The clear MVP so far is right-hander Dylan Cease. The veteran starter inked a massive contract last offseason, and he’s delivered on every penny. Through eight starts, Cease owns a sparkling 2.58 ERA, anchoring a rotation that’s been battered elsewhere.
One sentence sums up Toronto’s outlook: The Blue Jays will be fine once they get healthy. But health is a big “if.” For now, the verdict is clear—this team looks like a fraud until its roster returns to full strength. If the bats wake up and the bullpen stabilizes, the story could change quickly. But as of today, Toronto hasn’t proven it belongs in the contender conversation.